Julia D Zavariz1, Eleni Konstantatou2, Annamaria Deganello2, Diana Bosanac3, Dean Y Huang3, Maria E Sellars3, Paul S Sidhu3. 1. MD, Department of Radiology, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, SP, Brazil. 2. MD, Department of Radiology, King's College Hospital, Denmark Hill, London, United Kingdom. 3. FRCR, Department of Radiology, King's College Hospital, Denmark Hill, London, United Kingdom.
Abstract
The characterization of focal splenic lesions by ultrasound can be quite challenging. The recent introduction of contrast-enhanced ultrasound (CEUS) has come to play a valuable role in the field of imaging splenic pathologies, offering the possibility of an ionizing radiation-free investigation. Because CEUS has been incorporated into everyday clinical practice, malignant diseases such as focal lymphomatous infiltration, metastatic deposits, benign cysts, traumatic fractures, and hemangiomas can now be accurately depicted and characterized without the need for further imaging. More specifically, splenic traumatic fractures do not require additional imaging by computed tomography (with ionizing radiation exposure) for follow-up, because splenic fractures and their complications are safely imaged with CEUS. In the new era of CEUS, more patients benefit from radiation-free investigation of splenic pathologies with high diagnostic accuracy.
The characterization of focal splenic lesions by ultrasound can be quite challenging. The recent introduction of contrast-enhanced ultrasound (CEUS) has come to play a valuable role in the field of imaging splenic pathologies, offering the possibility of an ionizing radiation-free investigation. Because CEUS has been incorporated into everyday clinical practice, malignant diseases such as focal lymphomatous infiltration, metastatic deposits, benign cysts, traumatic fractures, and hemangiomas can now be accurately depicted and characterized without the need for further imaging. More specifically, splenic traumatic fractures do not require additional imaging by computed tomography (with ionizing radiation exposure) for follow-up, because splenic fractures and their complications are safely imaged with CEUS. In the new era of CEUS, more patients benefit from radiation-free investigation of splenic pathologies with high diagnostic accuracy.
Entities:
Keywords:
Microbubbles; Neoplasms; Spleen/diagnostic imaging; Ultrasonography/methods; Wounds and injuries
The search for efficient and less expensive imaging techniques is an ongoing
challenge worldwide, ultrasound being ideally positioned to provide comprehensive
imaging in a cost-effective manner. Ultrasound is a valuable tool in the study of
the spleen, with the ability to determine and monitor alterations in the size,
presence, and character of focal lesions, as well as diffuse alterations in the echo
pattern. In the last 20 years, contrast-enhanced ultrasound (CEUS) has seen advances
in several aspects (. Its use for
the examination of the spleen has been established in guidelines ( and documented in specific studies (. The
combination of microbubble contrast and ultrasound minimizes three challenges faced
in imaging: the deleterious effects of the ionizing radiation employed in computed
tomography (CT); the possibility of nephrotoxicity caused by the iodinated contrast
agents used in CT and magnetic resonance imaging (MRI); and the relatively high
costs of CT and MRI. Here, we present a pictorial review of the CEUS presentations
of a variety of splenic lesions, in comparison with those visible on B-mode
ultrasound, CT, and MRI.
CEUS
The contrast agents used in ultrasound are composed of small (3-5 µm)
microbubbles, with low solubility in blood, covered by a membrane-typically a lipid,
although proteins and polymers are also used (. These microbubbles are small enough to pass through the
lung capillaries but much larger than the molecules and particles used in CT and MRI
contrast agents. Therefore, these microbubbles do not cross the endothelium and cell
membrane, remaining exclusively in the intravascular space. The microbubble
ultrasound contrast agent in current use is not nephrotoxic, and its excretion is
essentially pulmonary, the inert gas (sulfur hexafluoride) being excreted via the
respiratory tract and the phospholipid shell being metabolized in the liver.Severe adverse events related to the use of microbubble contrast agents, anaphylactic
shock being the worst possible event, are rare, with an estimated prevalence of
0.0086%, considerably lower than that reported for the use of iodinated contrast
agents and comparable to those reported for most antibiotics and analgesics
(. In a large review of
the use of microbubble contrast in over 23,000 abdominal studies, there were no
deaths and only two anaphylactic reactions occurred, the incidence of serious events
being less than 1 event/10,000 examinations (. The authors reported that the most common adverse effects
were cough and back pain. Other possible effects are headache, nausea, and
ventricular extrasystole, the last possibly being relevant only in cardiac
examinations.
ULTRASOUND TECHNIQUE
Only after the spleen has been examined with B-mode and Doppler ultrasound should a
CEUS examination be performed. The operator must choose the best patient position to
allow visualization during respiration, taking both patient and operator comfort
into account. To improve visualization of the deep pole and subphrenic areas of the
spleen, for example, the patient can be placed in the lateral decubitus position or
imaged during inspiration (shallow, measured breaths are required for a lesion to be
visualized constantly throughout the examination). For better image definition, we
use the highest frequency possible, tailored to the depth of the target area.
Although it is normal practice to use a 3.5-5.0 MHz transducer, resolution is
improved with a 7.5 MHz transducer, albeit at the expense of the detection of less
obvious microbubbles (. At our
institution, a Siemens Acuson S2000 ultrasound system (Siemens Medical Solutions;
Mountain View, CA, USA) is used with the Lumason/SonoVue microbubble contrast agent
(Bracco; Milan, Italy). The microbubble contrast agent is injected intravenously via
a cannula inserted into the left antecubital fossa, at a dose of 1.2-2.4 mL; the
dose recommended by the manufacturer is 4.8 mL, which is now rarely needed. With the
improvements in the quality of the ultrasound systems, transducers, and image
processing, 1.2 mL of microbubble contrast is sufficient for examination of the
spleen, particularly in smaller patients. If necessary, the procedure can safely be
repeated after a 5-min interval.In all of the cases illustrated here, a low-mechanical-index technique-cadence
contrast pulse sequencing (Cadence CPS; Siemens Medical Solutions)-was used, the
mechanical index being set at or below 0.10, with split-screen imaging, which allows
the targeting of focal lesions. The mechanical index is a measure of the power of
the ultrasound beam, and a low mechanical index results in minimal microbubble
destruction, thus allowing enhanced imaging for a prolonged period (. During CEUS, a digital video clip
is recorded and still images are acquired as necessary.
CEUS OF THE NORMAL SPLEEN
The spleen is a solid organ, the superficial location of which makes it well suited
for CEUS examination. On CEUS, the perfusion dynamics of the spleen differ from
those of the liver, in which there is a dual blood supply, and mirrors the perfusion
characteristics seen on a contrast-enhanced CT scan, although with better definition
of the vascular components. In the early phase, microbubble contrast is seen within
the splenic artery and its branches, usually within the first 20 s after microbubble
contrast injection. Subsequently, the opacification becomes inhomogeneous, producing
the so-called "zebra" pattern, which mimics what is seen in the arterial phase of CT
(Figure 1). The splenic enhancement becomes
homogeneous after approximately 60 s, and the overall enhancement lasts for 5-7
min.
Figure 1
Zebra sign. A split-screen view. Striations are seen in a normally
perfused spleen in the early arterial phase, the CT analog of the zebra
sign.
Zebra sign. A split-screen view. Striations are seen in a normally
perfused spleen in the early arterial phase, the CT analog of the zebra
sign.
ABNORMALITIES OF THE SPLEEN ON CEUS
Splenic cyst
Splenic cysts (Figure 2) can be primary
(with cellular lining) or secondary. Most common primary cysts are simple,
congenital, unilocular cysts, occurring most commonly in children and
adolescents, predominantly in females. Less commonly, primary cysts are
parasitic, hydatid disease being the leading cause of such cysts in endemic
regions (. Secondary cysts
have no cellular lining and typically occur after trauma. Cysts can have
internal debris, the echogenicity of which makes them difficult to evaluate on
B-mode ultrasound, although primary congenital cysts are usually well defined,
with posterior acoustic enhancement. Following microbubble contrast
administration, the definition of the cyst is enhanced, no internal vascularity
is observed, and any internal debris is not enhanced.
Figure 2
Simple cyst. A: B-mode ultrasound showing a
well-circumscribed cystic structure (arrow) with a degree of a
posterior acoustic enhancement. B: A split-screen view.
The CEUS emphasized the features of the simple cyst (arrow), showing
a well-circumscribed, thin-walled mass with minimal posterior
acoustic enhancement.
Simple cyst. A: B-mode ultrasound showing a
well-circumscribed cystic structure (arrow) with a degree of a
posterior acoustic enhancement. B: A split-screen view.
The CEUS emphasized the features of the simple cyst (arrow), showing
a well-circumscribed, thin-walled mass with minimal posterior
acoustic enhancement.
Splenic abscess
At least 70% of splenic abscesses result from the hematogenous spread of
infection from elsewhere (.
The most common primary sources of such infection are the following: the
endocardium (endocarditis); the urinary tract; a surgical or traumatic wound;
and the appendix (appendicitis). Splenic abscesses are typically cystic, with a
thick, irregular wall, and contain debris and septations (. CEUS appearances can vary
depending on the number of internal septations. Generally, there is
hyperenhancement of the wall and enhancement of the internal septations (Figure 3). Again, as with a cyst, there
should be no enhancement of the debris or fluid/necrotic areas, the wall
irregularity and enhancement distinguishing an abscess from a cyst.
Figure 3
Abscess. A: Contrast-enhanced CT scan showing a
hypodense splenic lesion with a thick, irregular wall (arrows).
B: CEUS showing no internal enhancement and an
irregular wall in the larger abscess, with thickened, enhancing
septations in the smaller abscess (arrows).
Abscess. A: Contrast-enhanced CT scan showing a
hypodense splenic lesion with a thick, irregular wall (arrows).
B: CEUS showing no internal enhancement and an
irregular wall in the larger abscess, with thickened, enhancing
septations in the smaller abscess (arrows).
Granulomatous disease of the spleen
Granulomatous diseases such as sarcoidosis and tuberculosis can involve the
spleen; for example, 60% of sarcoidosispatients have splenic involvement
(. Usually, this
will manifest as splenomegaly with multiple nodules and evidence of sarcoidosis
elsewhere (, as depicted in
Figure 4.
Figure 4
Granulomatous disease. A: Contrast-enhanced CT scan
showing multiple low-density lesions within the spleen, less obvious
in the liver. B: Following microbubble contrast
administration, the splenic lesions remain hypovascular throughout
the CEUS examination but do show some internal vascular enhancement
(arrows). The patient depicted had a history of biopsy-proven
sarcoidosis
Granulomatous disease. A: Contrast-enhanced CT scan
showing multiple low-density lesions within the spleen, less obvious
in the liver. B: Following microbubble contrast
administration, the splenic lesions remain hypovascular throughout
the CEUS examination but do show some internal vascular enhancement
(arrows). The patient depicted had a history of biopsy-proven
sarcoidosis
Splenic infarction
Splenic infarction can arise as a result of a number of etiologies. The vast
majority are either infiltrative hematologic diseases that cause congestion of
the splenic circulation by abnormal cells or thromboembolic conditions that
produce obstruction of the large vessels (. The areas of infarction are usually well marginated
and wedge-shaped, and there is often evidence of an underlying cause. On CT, an
infarction might not be distinguishable from an abscess or an infiltrative
process, the subtle gray-scale ultrasound changes not clearly establishing the
cause. On CEUS, the distinction between the wedge-shaped, well-marginated
appearance of an infarction and the irregular borders of an abscess is easily
made (Figure 5).
Figure 5
Splenic infarction. A: Contrast-enhanced CT scan, in a
pre-assessment for liver transplantation, showing splenomegaly with
sharply demarcated low-density area in the posterior-inferior pole
of the spleen (arrow). B: A split-screen view.
Conventional ultrasound (right side of the screen) shows a
hypoechoic, heterogeneous lower pole of the spleen, and CEUS (left
side of the screen) shows a total absence of enhancement of the
lower pole of the spleen, confirming a large wedge-shaped infarction
(arrow). The patient was found to have aortic valve endocarditis.
Splenic infarction. A: Contrast-enhanced CT scan, in a
pre-assessment for liver transplantation, showing splenomegaly with
sharply demarcated low-density area in the posterior-inferior pole
of the spleen (arrow). B: A split-screen view.
Conventional ultrasound (right side of the screen) shows a
hypoechoic, heterogeneous lower pole of the spleen, and CEUS (left
side of the screen) shows a total absence of enhancement of the
lower pole of the spleen, confirming a large wedge-shaped infarction
(arrow). The patient was found to have aortic valve endocarditis.
Splenic trauma
It is challenging to diagnose traumatic splenic injury solely on the basis of
B-mode ultrasound images, and contrast-enhanced CT is often the modality of
choice for the assessment of the spleen after blunt abdominal trauma. However,
it must be noted that the addition of microbubble contrast to the ultrasound
examination makes the images equivalent to those of contrast-enhanced CT
(. CEUS can be used
at the bedside to delineate splenic injury in a traumapatient and is useful in
the follow-up imaging evaluation of such patients, to avoid the ionizing
radiation exposure of repeated CT examinations (Figure 6).
Figure 6
Splenic trauma. A: B-mode ultrasound showing subtle
heterogeneous abnormalities within the spleen (arrows).
B: Contrast-enhanced CT scan showing irregular
areas of hypodensity within the spleen in keeping with
intraparenchymal fractures (arrows). C: A split-screen
view. Following microbubble contrast administration, CEUS showed
areas of heterogeneous contrast uptake (fracture plane/hematoma)
with curvilinear and wedge-shaped areas of hypovascularity extending
to the hilum, consistent with fractures (arrows).
Splenic trauma. A: B-mode ultrasound showing subtle
heterogeneous abnormalities within the spleen (arrows).
B: Contrast-enhanced CT scan showing irregular
areas of hypodensity within the spleen in keeping with
intraparenchymal fractures (arrows). C: A split-screen
view. Following microbubble contrast administration, CEUS showed
areas of heterogeneous contrast uptake (fracture plane/hematoma)
with curvilinear and wedge-shaped areas of hypovascularity extending
to the hilum, consistent with fractures (arrows).
Splenic lymphoma
Lymphoma is the most common splenic malignancy, and splenic lymphoma is usually
the initial manifestation of systemic lymphoma, 10% to 30% of patients having
splenic involvement at presentation (. The imaging appearances range from diffuse
involvement to miliary nodules, mu tiple focal lesions and a solitary mass
(Figure 7). Larger lesions can appear
cystic due to central necrosis. The vascular pattern of lymphoma is thought to
be distinct from that of other focal malignant lesions of the spleen, with
preservation of less disordered vessels, particularly in the late phase of
enhancement. However not all splenic lesions in lymphomapatients show disease
infiltration, and radiologists should be aware of other entities that can
resemble focal splenic infiltration, such as focal fibrosis (Figure 8). A distinct form of low-grade
non-Hodgkin lymphoma is hairy-cell leukemia (Figure 9), which accounts for approximately 2% of all cases of
leukemia (.
Figure 7
Multiple splenic lymphoma. A: Contrast-enhanced CT scan
showing hypodense, lobulated soft-tissue lesions (arrows) in a
patient who presented with abdominal pain and distension.
B: B-mode ultrasound showing that lesions (arrows)
are ill-defined and of mixed reflectivity. C: Following
microbubble contrast administration, CEUS showed early arterial
enhancement and rapid washout (arrows) in the venous phase. The
appearances are suggestive of either metastatic disease or lymphoma.
Following splenectomy, this was proven to be a case of lymphoma.
Figure 8
Splenic fibrosis. A: In the routine follow-up CT of a
lymphoma patient, a new, hypodense lesion was observed.
B: B-mode ultrasound showing a hypoechoic lesion
(arrow). C: CEUS showing increased arterial enhancement
at 20 s and washout after 1 min (arrows). The suggested diagnosis
was disease infiltration, and splenectomy was performed. The lesion
was histologically proven to be focal fibrosis on a background of
chronic inflammatory changes.
Figure 9
Hairy-cell leukemia. A: CT scan showing a rounded,
hypodense soft-tissue lesion (arrow). B: On CEUS, the
lesion shows poor uptake in the arterial phase (arrows) and is
hypodense in comparison with the surrounding tissue, although
increasing in contrast in the venous phase (arrows).
Multiple splenic lymphoma. A: Contrast-enhanced CT scan
showing hypodense, lobulated soft-tissue lesions (arrows) in a
patient who presented with abdominal pain and distension.
B: B-mode ultrasound showing that lesions (arrows)
are ill-defined and of mixed reflectivity. C: Following
microbubble contrast administration, CEUS showed early arterial
enhancement and rapid washout (arrows) in the venous phase. The
appearances are suggestive of either metastatic disease or lymphoma.
Following splenectomy, this was proven to be a case of lymphoma.Splenic fibrosis. A: In the routine follow-up CT of a
lymphomapatient, a new, hypodense lesion was observed.
B: B-mode ultrasound showing a hypoechoic lesion
(arrow). C: CEUS showing increased arterial enhancement
at 20 s and washout after 1 min (arrows). The suggested diagnosis
was disease infiltration, and splenectomy was performed. The lesion
was histologically proven to be focal fibrosis on a background of
chronic inflammatory changes.Hairy-cell leukemia. A: CT scan showing a rounded,
hypodense soft-tissue lesion (arrow). B: On CEUS, the
lesion shows poor uptake in the arterial phase (arrows) and is
hypodense in comparison with the surrounding tissue, although
increasing in contrast in the venous phase (arrows).
Splenic metastases
Splenic metastases are rare and usually asymptomatic. The most common primary
neoplasms giving rise to such metastases are breast cancer, lung cancer,
colorectal cancer, ovarian cancer, and malignant melanoma (. On imaging, splenic
metastases typically appear as multiple solid nodules, occasionally appearing as
cystic nodules, particularly if the primary site is the ovary. On CEUS, the
behavior of splenic metastases is similar to that of hepatic metastases,
featuring washout and chaotic vessels (Figure
10).
Figure 10
Splenic metastasis. A: CT scan showing several hypodense
lesions in the liver and spleen, a large dominant lesion, with
central necrosis, being evident in the spleen. B:
B-mode ultrasound showing that the dominant lesion (within the
spleen) was ill-defined and heterogeneous, with possible central
necrosis. C: A split-screen view. CEUS showed that the
lesion was largely avascular and necrotic, with some septations.
This appearance is highly suggestive of necrotic metastases. This
patient had disseminated metastatic disease, the primary tumor being
identified as renal cell carcinoma.
Splenic metastasis. A: CT scan showing several hypodense
lesions in the liver and spleen, a large dominant lesion, with
central necrosis, being evident in the spleen. B:
B-mode ultrasound showing that the dominant lesion (within the
spleen) was ill-defined and heterogeneous, with possible central
necrosis. C: A split-screen view. CEUS showed that the
lesion was largely avascular and necrotic, with some septations.
This appearance is highly suggestive of necrotic metastases. This
patient had disseminated metastatic disease, the primary tumor being
identified as renal cell carcinoma.
Splenic hemangioma
Splenic hemangioma is congenital and is the most common benign lesion of the
spleen. It is typically an incidental finding, most often occurring in adults
between 30 and 50 years of age (. The prevalence of splenic hemangioma at autopsy ranges
from 0.3% to 14%. When large, a hemangioma can evolve to thrombosis, infarction,
or rupture (. Hemangioma
can also be multiple, as in Klippel-Trenaunay-Weber syndrome. Capillary
hemangiomas are usually small and echogenic on B-mode ultrasound, whereas they
show isoechoic enhancement on CEUS. Large cavernous hemangiomas can have a
combination of solid and cystic parts, with partial or complete centripetal
filling (Figure 11).
Figure 11
Splenic hemangioma. A: Contrast-enhanced CT scan showing
peripheral enhancement and delayed filling of the splenic lesion,
characteristic of a splenic hemangioma (arrows). B:
CEUS showing a classic splenic hemangioma (arrows) with avid
peripheral enhancement in the early phase (23 s) with some internal
filling, similar to the arterial-phase filling seen on CT. After
approximately 40 s, the hemangioma filled completely, with an
enhancement pattern similar to that of the surrounding spleen. Note
the similarity to the venous-phase CT scan of the same patient.
Splenic hemangioma. A: Contrast-enhanced CT scan showing
peripheral enhancement and delayed filling of the splenic lesion,
characteristic of a splenic hemangioma (arrows). B:
CEUS showing a classic splenic hemangioma (arrows) with avid
peripheral enhancement in the early phase (23 s) with some internal
filling, similar to the arterial-phase filling seen on CT. After
approximately 40 s, the hemangioma filled completely, with an
enhancement pattern similar to that of the surrounding spleen. Note
the similarity to the venous-phase CT scan of the same patient.
Splenic hamartoma
Splenic hamartoma, also known as splenoma, splenic adenoma, or nodular
hyperplasia, is a rare benign lesion that can occur at any age ( and can be associated with
hamartoma elsewhere in the body, particularly in conjunction with tuberous
sclerosis. Although splenic hamartoma is likely a focal developmental
disturbance, it has been suggested that it can arise from a proliferative
process or as a traumatic lesion. A splenic hamartoma is typically a
well-defined, solid, nodular lesion that compresses the surrounding splenic
tissue. In some cases, it is cystic or contains calcifications. When a splenic
hamartoma is solid, CEUS shows a varying degree of enhancement in the late
phase; when cystic, it presents like any other cystic structure and shows no
internal enhancement (Figure 12).
Figure 12
Splenic hamartoma. A: Venous-phase contrast-enhanced CT
scan showing a complex enhancing mass with central areas of fluid
density and a focus of calcification, causing alteration of the
contour of the spleen and retraction of the capsule. B:
T2-weighted MRI scan showing that the lesion is heterogeneous, with
an isointense to hyperintense signal. C: A split-screen
view. CEUS revealed that the lesion showed no internal enhancement,
consistent with a splenic hamartoma, as was all of the imaging.
Splenic hamartoma. A: Venous-phase contrast-enhanced CT
scan showing a complex enhancing mass with central areas of fluid
density and a focus of calcification, causing alteration of the
contour of the spleen and retraction of the capsule. B:
T2-weighted MRI scan showing that the lesion is heterogeneous, with
an isointense to hyperintense signal. C: A split-screen
view. CEUS revealed that the lesion showed no internal enhancement,
consistent with a splenic hamartoma, as was all of the imaging.
Splenic lymphangioma
Splenic lymphangioma is a rare benign tumor of unknown origin that is related to,
although much less common than, a hemangioma and is seen predominantly in
children. A splenic lymphangioma is normally asymptomatic. However, when the
tumor is large, it can be complicated by bleeding, consumptive coagulopathy, or
portal hypertension. Splenic lymphangiomas are usually subcapsular and typically
appear on ultrasound as multiple cysts, often with internal debris or septations
(
Figure 13). On CEUS, the septations and
capsule can show enhancement. On CT, splenic lymphangiomas appear as
thin-walled, low-attenuation masses without contrast enhancement. Mural
calcifications are occasionally present.
Figure 13
Splenic lymphangioma. A: B-mode ultrasound showing a
lobulated well-defined abnormality in the upper aspect of the
spleen, with septations and calcifications. B: On CEUS,
the lesion is more conspicuous, the lobulated outline and septations
being clearly demonstrated (arrow). The central aspect of the lesion
shows no contrast enhancement. C: The corresponding CT
scan confirmed the septations and foci of calcification.
Splenic lymphangioma. A: B-mode ultrasound showing a
lobulated well-defined abnormality in the upper aspect of the
spleen, with septations and calcifications. B: On CEUS,
the lesion is more conspicuous, the lobulated outline and septations
being clearly demonstrated (arrow). The central aspect of the lesion
shows no contrast enhancement. C: The corresponding CT
scan confirmed the septations and foci of calcification.
Splenic artery pseudoaneurysm
Splenic artery pseudoaneurysm is a rare entity that usually results from trauma,
pancreatitis, or surgery. If left untreated, a splenic pseudoaneurysm has a risk
of rupture of up to 37% and, if ruptured, a mortality rate of up to 90%; when
detected, the appropriate treatment can be endovascular or surgical, depending
on the size of the pseudoaneurysm, although its size is not predictive of the
risk of hemorrhage (. CEUS plays a significant
role in the imaging investigation of patients suspected of developing a
pseudoaneurysm (1 day to 4 months after a traumatic event). The CEUS imaging
findings are those of a rounded well-defined lesion usually lying within the
fracture plane (when post-traumatic) and demonstrate vascular enhancement
similar to that seen on contrast-enhanced CT, CEUS having the advantage of
real-time dynamic imaging (, as illustrated in Figure
14.
Figure 14
Splenic pseudoaneurysm identified during the follow-up evaluation of
a patient who had experienced low-energy blunt abdominal trauma,
with no evidence of pseudoaneurysm formation in the initial CT scan.
A split-screen view. CEUS showed a focus of hyperenhancement within
the fracture plane, consistent with a pseudoaneurysm.
Splenic pseudoaneurysm identified during the follow-up evaluation of
a patient who had experienced low-energy blunt abdominal trauma,
with no evidence of pseudoaneurysm formation in the initial CT scan.
A split-screen view. CEUS showed a focus of hyperenhancement within
the fracture plane, consistent with a pseudoaneurysm.
Splenunculi
Splenunculi are variants of normality, identified in 30% of autopsies (. On imaging, splenunculi
typically present adjacent to the splenic hilum; they can be single or multiple
and are usually ≤ 2 cm in diameter. Splenunculi can be ectopic and can
occur in a variety of locations, including the pancreas and scrotal sac. On CT
and ultrasound, splenunculi appear as well-defined nodules, with density similar
to that of the spleen itself (Figure 15).
On B-mode ultrasound, they have the same echotexture and echogenicity as the
spleen. On color Doppler ultrasound, an arterial hilum can be seen. The
principal differential diagnoses are a tumor in the tail of the pancreas and an
abnormal lymph node. On CEUS, splenunculi present enhancement features similar
to those of the rest of the splenic parenchyma. The enhancement pattern is an
important characteristic to differentiate a splenunculus from a pancreatic tail
tumor or an abnormal lymph node (.
Figure 15
Splenunculi. A: Non-contrast-enhanced CT scan, performed
for hematuria workup, showing a large, well-defined lesion adjacent
the spleen (arrow). B: A split-screen view. CEUS showed
that the lesion (arrows) was enhanced in a manner identical to that
of the adjacent splenic parenchyma, confirming that this was a large
splenunculus.
Splenunculi. A: Non-contrast-enhanced CT scan, performed
for hematuria workup, showing a large, well-defined lesion adjacent
the spleen (arrow). B: A split-screen view. CEUS showed
that the lesion (arrows) was enhanced in a manner identical to that
of the adjacent splenic parenchyma, confirming that this was a large
splenunculus.
CONCLUSION
CEUS is a powerful, accessible tool for the study of the spleen. Comparing CEUS with
B-mode ultrasound, the addition of microbubble contrast increases the conspicuity of
the majority of incidentally identified splenic lesions and can be used with
confidence to determine the nature of cysts, hemangiomas, infarctions, and
abscesses, as well as to facilitate the differentiation between benign and malignant
lesions. CEUS improves trauma imaging of the spleen, making it a practical tool for
increasing diagnostic reliability. The estimation of the extent of traumatic lesions
with CEUS is far more accurate than that achieved with B-mode ultrasound and similar
to that achieved with contrast-enhanced CT. CEUS of the spleen can also be used in
follow-up evaluations to identify complications associated with traumatic laceration
of the spleen, including pseudoaneurysm formation, and allows ionizing
radiation-free assessment of resolution of the injury.
Authors: F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott Journal: Ultraschall Med Date: 2011-08-26 Impact factor: 6.548
Authors: Michel Claudon; Christoph F Dietrich; Byung Ihn Choi; David O Cosgrove; Masatoshi Kudo; Christian P Nolsøe; Fabio Piscaglia; Stephanie R Wilson; Richard G Barr; Maria C Chammas; Nitin G Chaubal; Min-Hua Chen; Dirk Andre Clevert; Jean Michel Correas; Hong Ding; Flemming Forsberg; J Brian Fowlkes; Robert N Gibson; Barry B Goldberg; Nathalie Lassau; Edward L S Leen; Robert F Mattrey; Fuminori Moriyasu; Luigi Solbiati; Hans-Peter Weskott; Hui-Xiong Xu Journal: Ultrasound Med Biol Date: 2012-11-05 Impact factor: 2.998
Authors: Marco Picardi; Andrea Soricelli; Fabrizio Pane; Pio Zeppa; Emanuele Nicolai; Michele De Laurentiis; Francesco Grimaldi; Bruno Rotoli Journal: Radiology Date: 2009-05 Impact factor: 11.105
Authors: Deron J Tessier; William M Stone; Richard J Fowl; Maher A Abbas; James C Andrews; Thomas C Bower; Peter Gloviczki Journal: J Vasc Surg Date: 2003-11 Impact factor: 4.268
Authors: Harriet J Paltiel; Richard A Barth; Costanza Bruno; Aaron E Chen; Annamaria Deganello; Zoltan Harkanyi; M Katherine Henry; Damjana Ključevšek; Susan J Back Journal: Pediatr Radiol Date: 2021-05-12
Authors: Cyndi Mangano; Francesco Macrì; Simona Di Pietro; Michela Pugliese; Silvia Santoro; Nicola M Iannelli; Giuseppe Mazzullo; Rosalia Crupi; Massimo De Majo Journal: BMC Vet Res Date: 2019-06-11 Impact factor: 2.741